 Erythrocyte sedimentation rate predicts relapse survival early-stage Hodgkin disease EORTC Lymphoma Cooperative Group OBJECTIVE value mm/h Westergren erythrocyte sedimentation rate ESR early relapse survival therapy patients clinical stage II Hodgkin disease INTERVENTIONS patients early-stage Hodgkin disease separate multicenter clinical trials trials modern field radiotherapy patients multi-agent chemotherapy MAIN RESULTS ESR patterns pretherapy post-therapy assessments pattern normal pattern therapy normal therapy pattern therapy normal months therapy pattern pattern normal therapy normal therapy pattern therapy normal therapy multivariate analysis independent patients chemotherapy initial therapy protocol ESR predictors early relapse survival patients type chemotherapy number involved nodal areas Patients ESR pattern relative risk death times patients patterns Early relapse second important factor death irrespective ESR patients early relapse ESR relative risk death early relapse ESR relative risk death chemotherapy relative risk ESR initial therapy predictor early relapse death due Hodgkin disease CONCLUSION unexplained ESR therapy modern radiotherapy independent factors presence aggressive resistant Hodgkin disease elevated ESR predictive early relapse poor prognosis presence justifies aggressive therapy